The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"The Effects of Idarubicin Versus Other Anthracyclines for Induction Therapy of Patients With Newly Diagnosed Leukaemia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/. Accessed 27 April 2024.
The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/. Accessed April 27, 2024.
The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/
The Effects of Idarubicin Versus Other Anthracyclines for Induction Therapy of Patients With Newly Diagnosed Leukaemia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review
ID - 432908
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/
DB - Evidence Central
DP - Unbound Medicine
ER -